1 completed, 1 enrolling by invitation, 1 recruiting. 1 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Enrolling by invitation 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Beta-blocker: new trials by email Literature Review of Beta-blocker trials Research Report on Beta-blocker
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| N-of-1 Trial to Promote Beta-Blocker Titration in Heart Failure N-of-1 trials, Enhanced usual care - Heart Failure, Beta-blocker | Not applicable | Enrolling by invitation | Brigham and Women's Hospital | 50 | 2026-07-31 | 2026-09-21 |
| Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility echocardiography, Landiolol - Septic Shock, Tachycardia | Phase 3 | Recruiting | Centre Hospitalier Universitaire, Amiens | 360 | 2021-02-01 | 2025-08-24 |
| Esmolol in Sepsis Management:Evaluating Immunomodulatory Effects and Impact on Patient Outcomes esmolol - Sepsis, Lymphocyte Disorder T | Phase 2 | Completed | Lin Chen | 150 | 2021-01-01 | 2024-05-29 |
Autonomic Nervous System Diseases (1) · Cytokine Release Syndrome (1) · Heart Failure (1) · Sepsis (1) · Shock, Septic (1) · Tachycardia (1)
Cardiovascular Diseases (2) · Heart Diseases (2) · Infections (2) · Inflammation (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Shock (2) · Systemic Inflammatory Response Syndrome (2) · Arrhythmias, Cardiac (1) · Cardiac Conduction System Disease (1) · Nervous System Diseases (1) · Sepsis (1)
Single-Case Studies as Topic (1) · esmolol (1) · landiolol (1)
Brigham and Women's Hospital (1) · Centre Hospitalier Universitaire, Amiens (1) · Lin Chen (1)
China (1) · France (1) · United States (1)
P30AG064199 (1)